Look at biontech, before partnering with Pfizer selling the vaccine, the share price in November 2019 is less than $30, today, in less than 3 years, it's price is over $157. It could be us. So hold tight and vote no. Good things will happen.
- Forums
- ASX - By Stock
- RAP
- My Analysis: No synergy value in valuation
My Analysis: No synergy value in valuation, page-174
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)